FLUVOXAMINE MALEATE |
Luvox |
61718-82-9 |
Fevarin |
Luvox CR |
Fluvoxamine (maleate) |
DU23000 |
UNII-5LGN83G74V |
54739-20-7 |
5LGN83G74V |
C19H25F3N2O6 |
(Z)-but-2-enedioic acid;2-(E)-5-methoxy-1-4-(trifluoromethyl)phenylpentylideneaminooxyethanamine |
DU-23000 |
Faverin |
Floxyfral |
(E)-5-Methoxy-1-(4-(trifluoromethyl)phenyl)pentan-1-one O-(2-aminoethyl) oxime maleate |
1-Pentanone, 5-methoxy-1-(4-(trifluoromethyl)phenyl)-, O-(2-aminoethyl)oxime, (E)-, (Z)-2-butenedioate (1:1) |
MK-264 |
(E)-5-Methoxy-1-4-(trifluoromethyl)phenyl-1-pentanone O-(2-Aminoethyl)oxime Maleate |
(2Z)-but-2-enedioic acid; (E)-(2-aminoethoxy)({5-methoxy-1-4-(trifluoromethyl)phenylpentylidene})amine |
SMR000466268 |
SMR000653482 |
SR-01000075613 |
SME 3110 |
Depromel |
MFCD00269809 |
Fluvoxamine maleate USAN:USP |
Luvox (TN) |
NSC 309469 |
Fluvoxamine maleate, solid |
5-Methoxy-4-trifluoromethylvalerophenone (E)-O-2-aminoethyloxime monomaleate |
Fluvoxamine maleate- Bio-X |
5-Methoxy-4-(trifluoromethyl)valerophenone (E)-O-(2-aminoethyl)oxime, maleate (1:1) |
CHEMBL1409 |
SCHEMBL35225 |
MLS000028469 |
MLS000758271 |
MLS001076285 |
MLS001304717 |
MLS001401391 |
CHEBI:5139 |
DTXSID3042558 |
HY-B0103A |
Fluvoxamine maleate (JP17/USP) |
HMS1571G11 |
HMS2098G11 |
HMS3261D11 |
HMS3412A13 |
HMS3676A13 |
HMS3715G11 |
HMS3884K11 |
Pharmakon1600-01505604 |
(2-aminoethoxy)({5-methoxy-1-4-(trifluoromethyl)phenylpentylidene})amine; but-2-enedioic acid |
SME-3110 |
Tox21_500495 |
NSC309469 |
NSC759602 |
s1336 |
AKOS015961142 |
AC-9541 |
CCG-213494 |
CS-1839 |
NSC 759602 |
NSC-309469 |
NSC-759602 |
NCGC00093897-01 |
NCGC00093897-02 |
NCGC00261180-01 |
(E)-5-Methoxy-1-(4-(trifluoromethyl)phenyl)-1-pentanone O-(2-aminoethyl)oxime (Z)-2-butenedioate (1:1) |
AS-11790 |
BF164482 |
SMR000058449 |
EU-0100495 |
F0858 |
D00824 |
F 2802 |
J90043 |
739F183 |
A833394 |
SR-01000075613-1 |
SR-01000075613-3 |
SR-01000075613-4 |
SR-01000075613-6 |
Fluvoxamine maleate, British Pharmacopoeia (BP) Reference Standard |
Fluvoxamine maleate, European Pharmacopoeia (EP) Reference Standard |
Fluvoxamine maleate, United States Pharmacopeia (USP) Reference Standard |
5-Methoxy-1-(4-trifluoromethyl-phenyl)-pentan-1-one O-(2-amino-ethyl)-oxime maleate |
Fluvoxamine for system suitability, European Pharmacopoeia (EP) Reference Standard |
Fluvoxamine maleate, 1.0 mg/mL in methanol ((as free base)), certified reference material |
Fluvoxamine Maleate, Pharmaceutical Secondary Standard; Certified Reference Material |
(Z)-2-butenedioic acid; 2-(E)-5-methoxy-1-4-(trifluoromethyl)phenylpentylideneaminooxyethanamine |
(Z)-but-2-enedioic acid; 2-(E)-5-methoxy-1-4-(trifluoromethyl)phenylpentylideneaminooxyethanamine |
1-Pentanone, 5-methoxy-1-4-(trifluoromethyl)phenyl-,O-(2-aminoethyl)oxime, (1E)-, (2Z)-2-butenedioate (1:1) |
2-({(1E)-5-methoxy-1-4-(trifluoromethyl)phenylpentylidene}amino)oxyethanamine (2Z)-but-2-enedioate |